Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration.

[1]  L. Stone,et al.  Potassium‐ and capsaicin‐induced release of agmatine from spinal nerve terminals , 2007, Journal of neurochemistry.

[2]  Jisheng Han,et al.  The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats , 2006, Experimental Neurology.

[3]  K. Kitto,et al.  Supraspinally administered agmatine prevents the development of supraspinal morphine analgesic tolerance. , 2006, European journal of pharmacology.

[4]  L. Stone,et al.  Release of tritiated agmatine from spinal synaptosomes , 2006, Neuroreport.

[5]  Yangzheng Feng,et al.  Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: A potential mechanism for the anticonvulsive effects , 2005, Neuroscience Letters.

[6]  J. Sandkühler,et al.  Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo. , 2005, British journal of anaesthesia.

[7]  B. Grocholski,et al.  Pharmacodynamic and Pharmacokinetic Studies of Agmatine after Spinal Administration in the Mouse , 2005, Journal of Pharmacology and Experimental Therapeutics.

[8]  I. Paul,et al.  Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice , 2004, Neuroscience Letters.

[9]  Seyed Hasan Firoozabadi,et al.  Effects of nitric oxide on morphine self-administration in rat , 2003, Pharmacology Biochemistry and Behavior.

[10]  F. Aricioglu,et al.  Agmatine Inhibits Naloxone‐Induced Contractions in Morphine‐Dependent Guinea Pig Ileum , 2003, Annals of the New York Academy of Sciences.

[11]  Aaron C. Overland,et al.  Neuropharmacokinetic and Dynamic Studies of Agmatine (Decarboxylated Arginine) , 2003, Annals of the New York Academy of Sciences.

[12]  P. May,et al.  Agmatine Crosses the Blood‐Brain Barrier , 2003, Annals of the New York Academy of Sciences.

[13]  E. Ambrosio,et al.  Genetic differences in NMDA and D1 receptor levels, and operant responding for food and morphine in Lewis and Fischer 344 rats , 2003, Brain Research.

[14]  M. Papp,et al.  Selective Blockade of Drug-induced Place Preference Conditioning by ACPC, a Functional NDMA-receptor Antagonist , 2002, Neuropsychopharmacology.

[15]  M. Carroll,et al.  Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats , 2002, Pharmacology Biochemistry and Behavior.

[16]  Alcino J. Silva,et al.  A Pharmacogenetic Inducible Approach to the Study of NMDA/αCaMKII Signaling in Synaptic Plasticity , 2002, Current Biology.

[17]  W. Grody,et al.  Cloning and characterization of human agmatinase. , 2002, Molecular genetics and metabolism.

[18]  U. Schäfer,et al.  Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine‐mediated blood pressure reaction , 2002, British journal of pharmacology.

[19]  L. Rudolph-Owen,et al.  Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[20]  F. Colpaert,et al.  Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats , 2001, Pain.

[21]  A. Bender,et al.  Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. , 2001, Molecular pharmacology.

[22]  D. Reis,et al.  Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Kiss.  Role of nitric oxide in the regulation of monoaminergic neurotransmission , 2000, Brain Research Bulletin.

[24]  P. Garraghty,et al.  Role of NMDA receptors in adult primate cortical somatosensory plasticity , 2000, The Journal of comparative neurology.

[25]  W. Danysz,et al.  Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice. , 1999, European journal of pharmacology.

[26]  C. Parsons,et al.  Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data , 1999, Neuropharmacology.

[27]  D. Reis,et al.  Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. , 1999, The Journal of pharmacology and experimental therapeutics.

[28]  C. Parsons,et al.  Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization , 1999, Neuropharmacology.

[29]  D. Reis,et al.  Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain. , 1998, Journal of the autonomic nervous system.

[30]  İ. Uzbay,et al.  Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. , 1997, Life sciences.

[31]  G. Wilcox,et al.  Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. , 1997, The Journal of pharmacology and experimental therapeutics.

[32]  G. Gilad,et al.  Brain Polyamine Stress Response: Recurrence After Repetitive Stressor and Inhibition by Lithium , 1996, Journal of neurochemistry.

[33]  D. Reis,et al.  Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. , 1996, The Biochemical journal.

[34]  A. Zharkovsky,et al.  Nitric oxide synthesis inhibition attenuates morphine-induced place preference , 1996, Pharmacology Biochemistry and Behavior.

[35]  G. Pasternak,et al.  Modulation of opioid analgesia by agmatine. , 1996, European journal of pharmacology.

[36]  F. Vocci,et al.  The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal , 1995, Neuropsychopharmacology.

[37]  J. Gybels,et al.  The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain , 1995, Pain.

[38]  P. Chabrier,et al.  Selective inhibition of inducible nitric oxide synthase by agmatine. , 1995, Japanese journal of pharmacology.

[39]  D. Reis,et al.  Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.

[40]  J. Haley,et al.  Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse , 1992, Neuroscience Letters.

[41]  George L. Wilcox,et al.  The role of nitric oxide in hippocampal long-term potentiation , 1992, Neuron.

[42]  I. Reynolds,et al.  Reduction of NMDA receptors with dithiothreitol increases [3H]‐MK‐801 binding and NMDA‐induced Ca2+ fluxes , 1990, British journal of pharmacology.

[43]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.